Clinical trial

Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2

NCT04227535

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2020-02-03

PhaseN/A

Study timeline

Study start (actual)2020-02-03Date precision: day

Registry last updated2023-04-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interstitial Lung Diseaseunresolved

Interventions

Sponsors & collaborators

Assistance Publique - Hôpitaux de Parislead sponsor

Bristol-Myers Squibbcollaborator

Mapped research locations

ParisFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04227535 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.